The U.S. PRP and stem cell alopecia treatment market size is expected to reach USD 183.3 million by 2025 at a 5.1% CAGR during the forecast period

Thursday, November 15, 2018 Genetics & Stem Cells News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Nov. 14, 2018 /PRNewswire/ -- U.S. PRP (Platelet Rich Plasma) and Stem Cell Alopecia Treatment Market Size, Share

& Trends Analysis Report By Treatment, By End User (Dermatology Clinics, Hospitals), And Segment Forecasts, 2018 - 2025Read the full report: https://www.reportlinker.com/p05620871 The U.S. PRP and stem cell alopecia treatment market size is
expected to reach USD 183.3 million by 2025 at a 5.1% CAGR during the forecast period, according to a new report by Grand View Research, Inc. Factors contributing to the growth of this market include rise in disease awareness, increased treatment rate, and growing adoption of novel treatment therapies providing positive patient outcome. Moreover, lower incidences of negative side effects due to this therapy is anticipated to fuel demand for platelet rich plasma (PRP) and stem cell therapy.Adoption of PRP and stem cell therapy for alopecia is expected to increase owing to rise in number of patients preferring novel therapies over conventional therapies. In addition to this, shorter treatment duration, faster hair regrowth, and improved patient outcome are expected to drive demand for these therapies over the forecast period.By treatment type, PRP procedures accounted for the largest share of 58.1% in 2017 in terms of procedural volume. However, owing to lower prices of PRP procedures, stem cell therapy procedures accounted for the dominant revenue share in 2017, valued at USD 70.1 million. By end use, the dermatology clinics segment accounted for 85.0% of the total market revenue in 2017, owing to its lower therapy cost as compared to hospitals.The competitive landscape includes clinics such as Orange County Hair Restoration Center, Hair Sciences Center of Colorado, Evolution Hair Loss Institute, Savola Aesthetic Dermatology Center, PLC, NovaGenix, Virginia Surgical Center, and Hair Transplant Institute of Miami.Further key findings from the report suggest:• PRP procedures dominated the market in terms of volume in 2017, owing to its safety, effectiveness, and minimal chances of failure• Stem cell therapy accounted for the dominant revenue share in 2017 owing to higher prices of PRP procedures as compared to stem cell therapy. The segment was valued at USD 70.1 million in 2017• The dermatology clinic segment held the largest revenue share in 2017, accounting for USD 105.2 million• Some of the clinics providing PRP and stem cell therapy for alopecia in this market are Hair Sciences Center of Colorado, Anderson Center, PLC, Nova Genix, and Hair Transplant Institute of Miami.Read the full report: https://www.reportlinker.com/p05620871 About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

Cision View original content:http://www.prnewswire.com/news-releases/the-us-prp-and-stem-cell-alopecia-treatment-market-size-is-expected-to-reach-usd-183-3-million-by-2025-at-a-5-1-cagr-during-the-forecast-period-300750493.html

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store